Blog

Joost Rigter’s inspiring journey highlights the importance of accessibility in clinical research. From AI-driven tools to simplified communication, his story emphasizes how innovation can empower participants, ensuring they fully understand clinical trials and fostering a more inclusive approach to informed consent.

Local labs are a vital part of clinical trials, offering fast, cost-effective insights into safety and efficacy. But managing local lab data in the EDC often introduces unnecessary complexity, from inconsistent reference ranges to overwhelming queries. In this blog, we explore how to streamline workflows by simplifying protocols, focusing on critical data points, and designing intentional systems that reduce site and sponsor burden. Learn how smarter local lab management can lead to faster decisions, happier sites, and better outcomes for your trial.

Moving beyond compliance, quality culture drives clinical trial innovation through automated processes and measurable results.

A blueprint for engineering elegant eCOA solutions that make complex trials feel simple.

One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials

Discover FDA’s guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.

When it comes to Phase 4 clinical trials, Castor’s cutting-edge Real-World Evidence (RWE) platform is your key to unlocking unprecedented insights. Elevate Your Phase 4 Trials with our user-friendly EDC system that adapts to your unique Phase 4 needs. Effortlessly manage multi-region studies with our flexible platform. Reduce costs and accelerate timelines with our innovative AI solutions. Rest easy with our robust security and compliance features.

A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance of precise data utilization

A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance of precise data utilization

Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk on ethical and efficient drug development